back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-12-28 22:47 Tx date 2024-12-23 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,000
+20,000 vol $0.55 each |
154,500 | |
| Filed 2024-01-02 22:52 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$9,200
+20,000 vol $0.46 each |
54,500 | |
| Filed 2024-01-02 22:49 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,564
+3,400 vol $0.46 each |
134,500 | |
| Filed 2023-09-05 13:02 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,178
+3,300 vol $0.66 each |
131,100 | |
| Filed 2023-06-25 23:08 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,145
+3,300 vol $0.65 each |
127,800 | |
| Filed 2022-01-05 12:07 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+12,000 vol |
34,500 | |
| Filed 2022-01-05 11:33 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
124,500 | |
| Filed 2021-01-06 14:12 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+22,500 vol |
22,500 | |
| Filed 2021-01-06 14:09 Tx date 2018-05-01 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-06 12:54 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
112,500 | |
| Filed 2020-08-21 21:47 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+25,000 vol $0.60 each |
100,000 | |
| Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
75,000 | |
| Filed 2018-05-15 Tx date 2018-05-14 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
| Filed 2018-05-15 Tx date 2018-05-01 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|